| http://www.w3.org/ns/prov#value | - Dyadic???s innovative C1 platform technology is being further developed and leveraged to try and help solve this problem by enabling these companies to rapidly develop and produce new low cost and more effective biopharmaceuticals such as vaccines, antibodies and other therapeutic proteins.
|
